Brian Goff - Net Worth and Insider Trading

Brian Goff Net Worth

The estimated net worth of Brian Goff is at least $7 Million dollars as of 2023-03-27. Brian Goff is the EVP & Chief Commercial Officer of Alexion Pharmaceuticals Inc and owns about 36,257 shares of Alexion Pharmaceuticals Inc (ALXN) stock worth over $7 Million. Details can be seen in Brian Goff's Latest Holdings Summary section.

Transaction Summary of Brian Goff


Brian Goff Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Brian Goff owns 3 companies in total, including Alexion Pharmaceuticals Inc (ALXN) , Baxalta Inc (BXLT) , and Agios Pharmaceuticals Inc (AGIO) .

Click here to see the complete history of Brian Goff’s form 4 insider trades.

Insider Ownership Summary of Brian Goff

Ticker Comapny Transaction Date Type of Owner
ALXN Alexion Pharmaceuticals Inc 2020-06-08 EVP & Chief Commercial Officer
BXLT Baxalta Inc 2016-06-03 EVP and President & Hematology
AGIO Agios Pharmaceuticals Inc 2022-08-08 director & Chief Executive Officer

Brian Goff Latest Holdings Summary

Brian Goff currently owns a total of 1 stock. Brian Goff owns 36,257 shares of Alexion Pharmaceuticals Inc (ALXN) as of June 8, 2018, with a value of $7 Million.

Latest Holdings of Brian Goff

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ALXN Alexion Pharmaceuticals Inc 2018-06-08 36,257 182.50 6,616,903

Holding Weightings of Brian Goff

Brian Goff Form 4 Trading Tracker

According to the SEC Form 4 filings, Brian Goff has made a total of 1 transactions in Alexion Pharmaceuticals Inc (ALXN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Alexion Pharmaceuticals Inc is the sale of 1,645 shares on June 8, 2018, which brought Brian Goff around $194,982.

Insider Trading History of Brian Goff

Insider Trading Shares
Shares Change
Final Share
Current Price
Price Change Since Insider Trade (%)
Filing Date
Alexion Pharmaceuticals Inc
Alexion Pharmaceuticals Inc
Total 2
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Brian Goff Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Brian Goff Ownership Network

Ownership Network List of Brian Goff

No Data

Ownership Network Relation of Brian Goff

Brian Goff Owned Company Details

What does Alexion Pharmaceuticals Inc do?

Alexion Pharmaceuticals specializes in developing and marketing drugs for rare, life-threatening medical conditions. Its blockbuster product, Soliris, is approved for paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), generalized myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder (NMOSD). Next-generation Ultomiris is approved in PNH and aHUS. Strensiq and Kanuma target ultrarare metabolic diseases. Alexion's pipeline targets rare diseases with high unmet need in hematology, nephrology, metabolic diseases, neurology, cardiology, and other areas.

Who are the key executives at Alexion Pharmaceuticals Inc?

Brian Goff is the EVP & Chief Commercial Officer of Alexion Pharmaceuticals Inc. Other key executives at Alexion Pharmaceuticals Inc include EVP & Research & Development John J Orloff , EVP & Chief Compliance Officer Indrani Lall Franchini , and EVP & Chief Experience Officer Anne-marie Law .

Alexion Pharmaceuticals Inc (ALXN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Alexion Pharmaceuticals Inc (ALXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alexion Pharmaceuticals Inc (ALXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Alexion Pharmaceuticals Inc (ALXN)'s detailed insider trading history can be found in Insider Trading Tracker table.


NAS:ALXN Insider Transactions

Total 0
Shares Owned
Trade Price($)
Trade Percentage(%)
Price change since trade(%)
Share ownership details
Filing Date
Total 0

Brian Goff Mailing Address

Above is the net worth, insider trading, and ownership report for Brian Goff. You might contact Brian Goff via mailing address: C/o Alexion Pharmaceuticals, Inc, 100 College Street, New Haven Ct 06510.